EnzymeRx is interested in pursuing in-licensing opportunities for enzyme-based therapeutics and for technologies used in extending the half-life and reducing the immunogenicity of therapeutic proteins. We are also interested in small molecules and biologics that may have utility in the treatment of gout, arthritis and inflammatory disorders, or in the supportive care of oncology patients. Please contact us at info@enzymerx.com with your partnering opportunity.